These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32385918)

  • 1. Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer: LOGIK0801.
    Takayama K; Takeshita M; Inoue K; Ichiki M; Fujita M; Harada T; Shiraishi Y; Wataya H; Tokunaga S; Yamada T; Uchino J; Sugio K
    Oncologist; 2020 Aug; 25(8):e1146-e1157. PubMed ID: 32385918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer.
    Takayama K; Ichiki M; Matsumoto T; Ebi N; Akamine S; Tokunaga S; Yamada T; Uchino J; Nakanishi Y
    Oncologist; 2020 Mar; 25(3):208-e417. PubMed ID: 32162814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer.
    Bajetta E; Stani SC; De Candis D; Zaffaroni N; Zilembo N; Cortinovis D; Aglione S; Mariani L; Formisano B; Bidoli P
    Ann Oncol; 2003 Feb; 14(2):242-7. PubMed ID: 12562651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial.
    Grigorescu AC; Draghici IN; Nitipir C; Gutulescu N; Corlan E
    Lung Cancer; 2002 Jul; 37(1):9-14. PubMed ID: 12057861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer.
    Minami S; Kijima T; Shiroyama T; Okafuji K; Hirashima T; Uchida J; Imamura F; Osaki T; Nakatani T; Ogata Y; Yamamoto S; Namba Y; Otsuka T; Tachibana I; Komuta K; Kawase I
    BMC Res Notes; 2013 Jan; 6():3. PubMed ID: 23281805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: a randomized, phase-II study.
    Kusagaya H; Inui N; Karayama M; Nakamura Y; Kuroishi S; Yokomura K; Toyoshima M; Shirai T; Masuda M; Yamada T; Yasuda K; Suda T; Chida K
    Lung Cancer; 2012 Sep; 77(3):550-5. PubMed ID: 22705118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized phase II trial of gemcitabine plus carboplatin: biweekly versus standard schedules in patients with advanced non-small cell lung cancer.
    Hasegawa Y; Miura D; Kitamura C; Suzuki T; Kobayashi K; Sato N
    Chemotherapy; 2013; 59(5):346-53. PubMed ID: 24821009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non-Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group.
    Karampeazis A; Vamvakas L; Kentepozidis N; Polyzos A; Chandrinos V; Rigas G; Christofyllakis C; Kotsakis A; Hatzidaki D; Pallis AG; Georgoulias V
    Clin Lung Cancer; 2016 Nov; 17(6):543-549. PubMed ID: 27397849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I/II study of carboplatin plus gemcitabine for elderly patients with advanced non-small cell lung cancer: West Japan Thoracic Oncology Group Trial (WJTOG) 2905.
    Kurata T; Hirashima T; Iwamoto Y; Kawaguchi T; Ikeda N; Tsuboi M; Sawa T; Ishiguro T; Aoki T; Kotani Y; Nakagawa K; Fukuoka M
    Lung Cancer; 2012 Jul; 77(1):110-5. PubMed ID: 22306126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer.
    Uramoto H; Nakanishi R; Nagashima A; Uchiyama A; Inoue M; Osaki T; Yoshimatsu T; Sakata H; Nakanishi K; Yasumoto K
    Anticancer Res; 2010 Nov; 30(11):4695-9. PubMed ID: 21115926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Feasibility and response of gemcitabine and carboplatin biweekly combination chemotherapy for patients with postoperative recurrence non-small cell lung cancer].
    Mori S; Kobayashi R; Okuda K; Ogawa S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Mitsudomi T
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):57-61. PubMed ID: 19151564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer.
    Takayama K; Ichiki M; Tokunaga S; Inoue K; Kawasaki M; Uchino J; Nakanishi Y
    Oncologist; 2019 Nov; 24(11):1420-e1010. PubMed ID: 31332099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.
    Brodowicz T; Krzakowski M; Zwitter M; Tzekova V; Ramlau R; Ghilezan N; Ciuleanu T; Cucevic B; Gyurkovits K; Ulsperger E; Jassem J; Grgic M; Saip P; Szilasi M; Wiltschke C; Wagnerova M; Oskina N; Soldatenkova V; Zielinski C; Wenczl M;
    Lung Cancer; 2006 May; 52(2):155-63. PubMed ID: 16569462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.
    Binder D; Schweisfurth H; Grah C; Schäper C; Temmesfeld-Wollbrück B; Siebert G; Suttorp N; Beinert T
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):143-50. PubMed ID: 17031643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer.
    Jang J; Kim HK; Cho BC; Lee KH; Yun HJ; Woo IS; Song HS; Ryoo HM; Kim CH; Sun DS; Shin JW
    Cancer Chemother Pharmacol; 2017 May; 79(5):873-880. PubMed ID: 28341958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer.
    Grønberg BH; Bremnes RM; Fløtten O; Amundsen T; Brunsvig PF; Hjelde HH; Kaasa S; von Plessen C; Stornes F; Tollåli T; Wammer F; Aasebø U; Sundstrøm S
    J Clin Oncol; 2009 Jul; 27(19):3217-24. PubMed ID: 19433683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of biweekly carboplatin, gemcitabine, and bevacizumab as first-line treatment in patients with stage IIIB/IV NSCLC.
    Dudek AZ; Kumar P; H Thaw SS; Cao Q; Pawloski P; Larson T
    Am J Clin Oncol; 2014 Apr; 37(2):140-3. PubMed ID: 23111363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of first-line chemotherapy with weekly carboplatin plus gemcitabine in advanced non-small cell lung cancer.
    Mori K; Kamiyama Y; Kasai H; Kodama T
    Chemotherapy; 2012; 58(1):78-83. PubMed ID: 22377616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
    Paccagnella A; Oniga F; Bearz A; Favaretto A; Clerici M; Barbieri F; Riccardi A; Chella A; Tirelli U; Ceresoli G; Tumolo S; Ridolfi R; Biason R; Nicoletto MO; Belloni P; Veglia F; Ghi MG
    J Clin Oncol; 2006 Feb; 24(4):681-7. PubMed ID: 16446341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and feasibility of gemcitabine and carboplatin as first-line chemotherapy in elderly patients with advanced non-small cell lung cancer.
    Lim KH; Lee HY; Song SY
    Chin Med J (Engl); 2013; 126(24):4644-8. PubMed ID: 24342304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.